Osang Healthcare Co.,Ltd (KOSDAQ:036220)
 12,920
 -130 (-1.00%)
  Oct 31, 2025, 3:30 PM KST
Revenue by Product
Financials in millions KRW. Fiscal year is January - December.
 Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 | 
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 | 
| Biochemical Diagnosis - Blood Sugar Meter | 58.73B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Biochemical Diagnosis - Blood Sugar Meter Growth | 23.68% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Biochemical Diagnosis - Glycated Hemoglobin Meter | 11.18B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Biochemical Diagnosis - Glycated Hemoglobin Meter Growth | 13.21% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Immunodiagnosis | 3.61B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Immunodiagnosis Growth | -98.76% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Molecular Diagnosis | 3.11B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Molecular Diagnosis Growth | 15.31% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Biochemical Diagnosis - Cholesterol/Liver Disease Meter | 2.00B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Biochemical Diagnosis - Cholesterol/Liver Disease Meter Growth | 2.15% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Merchandise | 1.38B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Merchandise Growth | -30.27% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Other Product | 443.00M |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Other Product Growth | 58.21% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Biochemical Diagnosis - Other | 39.00M |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Biochemical Diagnosis - Other Growth | -29.09% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Other | 14.00M |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Other Growth | -95.07% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Molecular Diagnostics Kit - Merchandised | - |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Molecular Diagnostics Kit - Merchandised Growth | - |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Others - Manufactured Products | - |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Others - Manufactured Products Growth | - |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Other | 14.00M |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Other Growth | -95.07% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
 Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 | 
|---|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 | 
| Other | 7.91B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Other Growth | 46.07% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Europe | 24.59B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Europe Growth | 19.61% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| South Korea | 16.01B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| South Korea Growth | -10.03% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| South America | 13.45B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| South America Growth | 63.08% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Asia | 11.99B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Asia Growth | 7.83% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| North America | 6.53B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| North America Growth | -97.77% |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Other | 7.91B |  Log In |  Log In |  Log In |  Log In | Upgrade  | 
| Other Growth | 46.07% |  Log In |  Log In |  Log In |  Log In | Upgrade  |